orphan-drug

22 February 2018
Pharmablue
About the "Exploitant" status French regulatory authorities require having an « Exploitant » authorized and...
Driving access to Innovative Therapies Through Strategic Partnerships Innovation is only meaningful when it reaches...
Known as Expanded Access Programs in the US, early access programs (EAP) allow access to...